Ambrose Stated News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ambrose Stated. Real-time updates on events, politics, business and more.

Severe Asthma Management: Exploring the Mechanism of Action in Tezepelumab and Omalizumab

June 1, 2023

Dr. Jean-Pierre Llanos Ackert and Dr. Chris Ambrose discuss the latest data on the breakthrough biologic for severe asthma.

Llanos Ackert Astrazeneca Chris Ambrose Amgen Jean Pierre Llanos Ackert Chris Ambrose Jean Pierre Llanos Ackert Global Medical Affairs

Source: hcplive.com

JP Llanos Ackert, MD, C Ambrose, MD: New Data Support Tezepelumab for Asthma

May 31, 2023

Investigators Dr. Jean-Pierre Llanos Ackert and Dr. Chris Ambrose share insight on the efficacy of tezepelumab in severe, uncontrolled asthma, and baseline predictors of enhanced response which support tezepelumab as a promising biologic treatment option.

United States Jean Pierre Llanos Ackert Chris Ambrose Llanos Ackert International Conference Global Medical Affairs

Source: hcplive.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Ambrose Stated News Today

Severe Asthma Management: Exploring the Mechanism of Action in Tezepelumab and Omalizumab

JP Llanos Ackert, MD, C Ambrose, MD: New Data Support Tezepelumab for Asthma

Explore More Categories